title: Hepatitis C virus non-structural 5A abrogates signal transducer and activator of transcription-1 nuclear translocation induced by IFN-alpha through dephosphorylation.
abstract: OBJECTIVE
  To study the effect of Hepatitis C virus non-structural 5A (HCV NS5A) on IFNalpha induced signal transducer and activator of transcription-1 (STAT1) phosphorylation and nuclear translocation.
  
  
  METHODS
  Expression of STAT1 Tyr701 phosphorylation at different time points was confirmed by Western blot, and the time point when p-STAT1 expressed most, was taken as the IFN induction time for further studies. Immunocytochemistry was used to confirm the successful transient transfection of NS5A expression plasmid. Immunofluorescence was performed to observe if there was any difference in IFNalpha-induced STAT1 phosphorylation and nuclear translocation between HCV NS5A-expressed and non-HCV NS5A-expressed cells. Western blot was used to compare the phosphorylated STAT1 protein of the cells.
  
  
  RESULTS
  Expression of HCV NS5A was found in the cytoplasm of P(CNS5A-transfected ) Huh7 cells, but not in the PRC/CMV transfected or non-transfected cells. STAT1 Tyr701 phosphorylation was found strongest in 30 min of IFN induction. STAT1 phosphorylation and nuclear import were much less in the presence of HCV NS5A protein in contrast to P( RC/CMV-transfected ) and non-transfected cells under fluorescent microscopy, which was further confirmed by Western blot.
  
  
  CONCLUSIONS
  HCV NS5A expression plasmid is successfully transfected into Huh7 cells and HCV NS5A protein is expressed in the cytoplasm of the cells. IFN-alpha is able to induce STAT1 phosphorylation and nuclear translocation, and this effect is inhibited by HCV NS5A protein, which might be another possible resistance mechanism to interferon alpha therapy.
authors: Institute of Hepatology and Department of Infectious Diseases, The Second Xiangya Hospital, Central South University, Changsha 410011, Hunan Province, China. guozhonggong@yahoo.com
authors: Guo-Zhong
authors: GZ
authors: Gong
authors: Jie
authors: J
authors: Cao
authors: Yong-Fang
authors: YF
authors: Jiang
authors: Yang
authors: Y
authors: Zhou
authors: Bo
authors: B
authors: Liu
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D045744:Cell Line, Tumor; D024882:Drug Resistance, Viral / Q000502:physiology; D016174:Hepacivirus / Q000187:drug effects / Q000502:physiology; D006526:Hepatitis C / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D010766:Phosphorylation / Q000187:drug effects; D010957:Plasmids; D011994:Recombinant Proteins; D050794:STAT1 Transcription Factor / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology*; D014162:Transfection; D017361:Viral Nonstructural Proteins / Q000502:physiology*; D012324:RNA-Dependent RNA Polymerase
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D050794:STAT1 Transcription Factor; D017361:Viral Nonstructural Proteins; C494079:STAT1 protein, human; C087036:NS-5 protein, hepatitis C virus; D012324:RNA-Dependent RNA Polymerase
references: Proc Natl Acad Sci U S A. 1999 May 11;96(10):5533-8
references: 10318918
references: Eur J Biochem. 1997 Sep 15;248(3):615-33
references: 9342212
references: J Gen Virol. 1997 Oct;78 ( Pt 10):2397-410
references: 9349458
references: Pathol Biol (Paris). 2004 Nov;52(9):505-10
references: 15531113
references: J Hepatol. 2007 May;46(5):759-67
references: 17275127
references: Virology. 1997 Apr 14;230(2):217-27
references: 9143277
references: J Virol. 1995 Jul;69(7):3980-6
references: 7769656
references: J Virol. 2006 Jun;80(12 ):5908-18
references: 16731929
references: J Virol. 2005 Oct;79(20):12828-39
references: 16188985
references: Cell Death Differ. 2003 Jan;10 Suppl 1:S27-38
references: 12655344
references: Virology. 2002 Aug 1;299(2):164-71
references: 12202219
references: Cell. 1995 Jul 28;82(2):241-50
references: 7543024
references: Gastroenterology. 2005 Apr;128(4):1034-41
references: 15825084
references: Sci STKE. 2003 Aug 12;2003(195):RE13
references: 12915721
references: Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9599-604
references: 11481452
references: J Gen Virol. 2004 Apr;85(Pt 4):959-69
references: 15039538
references: Science. 1999 Jul 2;285(5424):107-10
references: 10390359
references: J Biol Chem. 1997 Sep 26;272(39):24542-9
references: 9305919
references: J Med Virol. 2004 Aug;73(4):536-47
references: 15221897
references: Dig Dis Sci. 2002 Jun;47(6):1195-205
references: 12064791
references: Science. 2003 May 16;300(5622):1145-8
references: 12702807
references: J Clin Invest. 1995 Jul;96(1):224-30
references: 7542279
references: Viral Immunol. 2002;15(1):95-119
references: 11952150
references: Mol Cell Biol. 1997 Nov;17(11):6508-16
references: 9343414
references: J Gen Virol. 2004 Sep;85(Pt 9):2485-502
references: 15302943
references: Microbiol Immunol. 2001;45(12):829-40
references: 11838900